• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Mankind Pharma Limited — Board Meeting, 03-02-2026: Outcome of Board Meeting

    03-02-2026 | 04:13 pm

    Mankind Pharma's Board approved Q3 & 9-month results. Consolidated Revenue from Operations hit ₹3,567.20 Cr, with Profit after Tax at ₹408.75 Cr. Profits were impacted by ₹106.59 Cr in exceptional items, including new Labour Code provisions and asset impairment.

    No comments yet. Be the first to comment!

    All announcements from Mankind Pharma Limited